Peptide TherapeuticsPeer Reviewed
SPP1 as a biomarker for idiopathic membranous nephropathy progression and its regulatory role in inflammation and fibrosis.
Authors (16)
Shuting Pang
Rongbin ZhouCenter for Genomic and Personalized Medicine, Guangxi key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, University Engineering Research Center of Digital Medicine and Healthcare, Guangxi Medical University, Nanning, Guangxi Zhuang, China.
Zige Liu
Boji Xie
Frontiers in immunology
Unknown
Published
Jan 01, 2025
Abstract
Abstract not available - data parsing issue resolved
Keywords
SPP1fibrosisidiopathic membranous nephropathyinflammationproximal tubular cells
Article Metrics
Sourcepubmed
Related Research
Explore more articles in this research category to discover related studies and findings.